Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KiSS trial of early levetiracetam for delirium prevention and treatment during septic shock
2023-510449-51-00Phase 3Authorised
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in delirium and septic shock comparing Levetiracetam with Placebo (2 arms). Primary endpoint: Days alive without delirium or coma through day 14. Planned start Jul 2025; status: authorised.
02
Drugs
levetiracetam
03
Conditions
deliriumseptic shock
Beyond the preview
Go deeper on 2023-510449-51-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-510449-51-00.